Calls for papers
-
Summit Biosciences has received almost $150k in qualifying therapeutic discovery project (QTDP) grants for development of its synthetic THC nasal spray. According to Summit, it will use the money to hire new personnel for the… Read more . . .
-
The Alberta Idealized Throat, a new cascade impactor induction port designed to represent conditions in the human throat better than the standard USP/Ph.Eur induction port, will be introduced by Copley Scientific at DDL 21. The… Read more . . .
-
Richard Hawkins, who founded Pharmaco, now PPD Development, has joined the board of directors of Texas-based inhalation drug development company Savara. The company is developing a number of dry powder aerosol medicines based on its… Read more . . .
-
German biotech company bitop AG announced that it has begun enrolling patients in a clinical trial of its Ectoin inhalation solution for the treatment of airway inflammation. In addition to the inhalation solution, bitop is… Read more . . .
-
The United States Patent and Trademark Office has found that Hovione’s method for making flumethasone and an analogue was not obvious, upholding the company’s patent. A previous reexamination based on a 2005 claim had found… Read more . . .
-
According to ISTA Pharmaceuticals, the company will file an Investigational New Drug (IND) application for its bepotastine nasal spray for allergic rhinitis by the end of this year. ISTA, which already markets a bepotastine opthalmic… Read more . . .
-
Astech Projects says it has added more dose collection chambers to its Xelox 1 Series Automated Sample Delivery Workstation to facilitate collection of samples for content uniformity testing. The workstation performs automatic waste firing of… Read more . . .
-
An article in the November issue of the American Journal of Medicine reports that a study of almost 400,000 COPD and asthma patients showed a 34% increase in the rate of Type 2 diabetes among those using… Read more . . .
-
Almirall and Forest Laboratories have announced that a Phase 3 study of their aclidinium bromide DPI for the treatment of COPD produced significant improvement from baseline in FEV1 at clinical doses but underperformed when compared… Read more . . .
-
A group calling itself Safe and Healthy Use of Nasal sprays (SHUN) is trying to get out the message that "Addiction to over-the-counter medicated nasal spray is a serious problem in the United States" and… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland